Intravenous (IV) Therapy and Vein Access: Global Markets

Report Scope

This report examines the global market for IV therapy and venous access devices, providing a comprehensive review of applications across several healthcare facility settings.

The study covers a range of IV solutions and devices used in therapeutic applications. BCC Research has analyzed critical market components, including types of IV solutions. These include general IV solutions, parenteral nutrition IV solutions and premixed drug IV solutions; infusion pumps such as general infusion pumps, specialized infusion pumps, portable and disposable infusion pumps, and implantable infusion pumps; and venous access devices such as peripheral IV catheters and central venous catheters.

Products for each IV solution and set market segment include:

General IV solutions and sets: Includes normal saline, hypertonic saline, Lactated Ringer’s, Dextran and dextrose in water, along with IV sets, containers and accessories for care settings.

Parenteral nutrition IV solutions and sets: Covers nutrient-rich solutions (carbohydrates, lipid emulsions, amino acids, trace elements, vitamins, minerals) with accompanying IV sets and accessories for care settings.

Premixed IV solutions and sets: Includes premixed drugs (antibiotics, pain management, cardiovascular agents) with drug-delivery systems, containers, and accessories for care settings.

This report addresses regulatory aspects, including technological advances (patents and approvals), and the latest trends, preferences and developments in IV therapy. It includes market projections and market share analysis for global IV therapy and venous access market. It covers emerging technologies, such as AI-integrated ultrasonography for automatic vein measurement to prevent IV catheter failure, and AI-enabled, ultrasound-guided handheld robotic devices for femoral vascular. The market is segmented by region into North America, Asia-Pacific, Europe, and Rest of the World (RoW), and analyzes the markets for the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.

Report Includes

92 data tables and 53 additional tables

Analyses of the global market trends for intravenous (IV) therapy and vein access devices, with revenue data (sales figures) from 2021-2023, forecasts for 2024, and projected CAGRs through 2029

Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type, application, end user and region

Discussion of the market potential and opportunities in the medical device industry, along with an analysis of the competitive environment, regulatory scenario, and technological advances

Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors

Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

Patent analysis featuring key granted and published patents

Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

Company profiles, including BD, B. Braun, Fresenius SE & Co. KGaA, Baxter, and Medtronic

Companies Mentioned

ANGIODYNAMICS
BAXTER
B. BRAUN SE
BD
CARDINAL HEALTH
COOK
FRESENIUS SE & CO. KGAA
ICU MEDICAL INC.
INTEGRATED MEDICAL SYSTEMS INC.
IRADIMED CORP.
MEDTRONIC
PFIZER INC.
TERUMO CORP.
VYGON SAS
WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.